These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3624505

  • 1. Imipramine blood levels and clinical outcome.
    Rigal JG, Albin HC, Duchier AR, D'Aulnay JM, Fenelon JH, Vincon GA, Demotes-Mainard FM.
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [Abstract] [Full Text] [Related]

  • 2. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J, Wasieczko A.
    Psychiatr Pol; 1991 Aug; 25(1):54-60. PubMed ID: 1780375
    [Abstract] [Full Text] [Related]

  • 3. The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramine.
    Strober M, Freeman R, Rigali J.
    Psychopharmacol Bull; 1990 Aug; 26(1):80-4. PubMed ID: 2196630
    [Abstract] [Full Text] [Related]

  • 4. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA, Perini GI, Molnar G, Jusko WJ.
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [Abstract] [Full Text] [Related]

  • 5. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH, Weller EB, Weller RA.
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [Abstract] [Full Text] [Related]

  • 6. Combined treatment with imipramine and mianserin. A controlled pilot study.
    Lauritzen L, Clemmesen L, Klysner R, Loldrup D, Lunde M, Schaumburg E, Waarst S, Bech P.
    Pharmacopsychiatry; 1992 Jul; 25(4):182-6. PubMed ID: 1528957
    [Abstract] [Full Text] [Related]

  • 7. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z, Dziedzicka-Wasylewska M, Daniel WA, Wójcikowski J, Dudek D, Wróbel A, Zieba A.
    Pol J Pharmacol; 2004 Jul; 56(6):735-42. PubMed ID: 15662086
    [Abstract] [Full Text] [Related]

  • 8. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E, Pollicino AM, Avenoso A, Campo GM, Caputi AP.
    Int J Clin Pharmacol Res; 1993 Jul; 13(3):167-71. PubMed ID: 8225700
    [Abstract] [Full Text] [Related]

  • 9. Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients.
    Hrdina PD, Bakish D, Swenson S, Lapierre YD.
    J Psychiatry Neurosci; 1991 Mar; 16(1):25-9. PubMed ID: 2049367
    [Abstract] [Full Text] [Related]

  • 10. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
    Rigal J, Albin H, Fança X, Demotes-Mainard F, Vinçon G.
    J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
    Wells BG, Evans RL, Ereshefsky L, Antal EJ, Lobeck F, Rawls WN, Hamann G, Grimmig J, Smith RB.
    J Clin Psychiatry; 1988 Oct; 49(10):394-9. PubMed ID: 3049560
    [Abstract] [Full Text] [Related]

  • 12. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine.
    Rausch JL, Moeller FG.
    Psychiatry Res; 1991 Mar; 36(3):299-305. PubMed ID: 2062971
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA.
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [Abstract] [Full Text] [Related]

  • 14. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG, Adan F, Lee A, Cooper TB, Mandeli J, Casey E.
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [Abstract] [Full Text] [Related]

  • 15. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N, Siobud-Dorocant E, Even C, Slama F, Dardennes R.
    Encephale; 2001 Feb; 27(4):373-6. PubMed ID: 11686060
    [Abstract] [Full Text] [Related]

  • 16. Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients.
    Gelenberg AJ, Wojcik JD, Lydiard RB, McCormick MG, Falk WE, Hicks RH, Curren FC, Cohen BM.
    J Clin Psychiatry; 1984 Feb; 45(2):54-56, 57-9. PubMed ID: 6363397
    [Abstract] [Full Text] [Related]

  • 17. Targeting imipramine dose in children with depression.
    Sallee F, Stiller R, Perel J, Rancurello M.
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [Abstract] [Full Text] [Related]

  • 18. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
    Amsterdam JD, Brunswick DJ, Potter L, Rickels K.
    Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
    [Abstract] [Full Text] [Related]

  • 19. Endogenous depression and imipramine levels in the blood.
    Costa D, Predescu V, Vişan-Ionescu I, Ciurezu T.
    Psychopharmacology (Berl); 1980 Mar; 70(3):291-4. PubMed ID: 6777803
    [Abstract] [Full Text] [Related]

  • 20. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE, Lyle FA, Higginbotham W.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.